A Pilot Trial of Dextroamphetamine for Methamphetamine Dependence
Status:
Completed
Trial end date:
2011-08-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the safety and effectiveness dextroamphetamine to help
methamphetamine users quit or cut down on their use. The study lasts for 9 weeks. Eligible
participants will attend research visits twice per week, and will receive individual
counseling sessions once per week for all 9 weeks. 50% of the participants will receive the
active medication while the other 50% will receive the placebo (sugar pill). Neither the
participant or the study team will know if the participant is receiving the placebo or active
drug.
Phase:
Phase 2
Details
Lead Sponsor:
California Pacific Medical Center Research Institute